PROM1 and cancer: We will also discuss the role of CD133+ extracellular membrane vesicles (EVs), which have received considerable attention in recent years, and the lessons learned from studies using CD133-deficient animals and CD133-silenced human CD34+ HSPCs as well as studies focused on cancers in which CD133 is upregulated.